LeMaitre Vascular (LMAT) Stock: Buy, Sell, or Hold?
LMAT - LeMaitre Vascular, Inc.
$80.59
1.79 (2.27%)
â˛
5d:
+0.12%
30d:
-1.88%
90d:
-12.72%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LMAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LMAT is fairly priced but lacks strong directional signals. At -7.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LMAT is fairly priced but lacks strong directional signals. At -7.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$112.38
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$69.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LMAT is currently trading at $80.59, which is considered fair relative to its 30-day fair value range of $77.04 to $86.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.4) compared to its historical average (31.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This pessimistic expectation contrasts with the company's recent 22.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LMAT is in a strong downtrend. The price is currently testing key support at $78.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $107.00 (+32.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LMAT is in a strong downtrend. The price is currently testing key support at $78.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $107.00 (+32.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$77.04 -
$86.60
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.7%
Protect Your Profits
Holding LMAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 32.8% below Wall St target ($107.00)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$77.04 -
$86.60
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$3.22
(4.0%)
Support & Resistance Levels
Support Level
$78.29
Resistance Level
$83.07
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.35
Wall Street Target
$107.00
(+32.8%)
Revenue Growth (YoY)
9.6%
Earnings Growth (YoY)
22.6%
Profit Margin
25.0%
Valuation Discount vs History
-7.2% cheaper
PE vs Historical
25.4 vs 31.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.2%
(market-implied from PE analysis)
1-Year Target
$74.79
(-7%)
2-Year Target
$69.40
(-14%)
3-Year Target
$64.41
(-20%)
3-Yr Target (if PE normalizes)
(PE: 25â32)
$80.53
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.4, Growth: 10.4%)
$108.50
(+35%)
Base:
(SPY PE: 20.2, Growth: 10.4%)
$86.32
(+7%)
Bear:
(PE: 17.1, Growth: 10.4%)
$73.37
(-9%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 27.84 | Current EPS (TTM): $2.83
Bull Case
$97.36
(+21%)
Analyst growth 12.3%, PE expands to 30.6
Base Case
$88.51
(+10%)
Market implied 12.3%, PE stable at 27.8
Bear Case
$53.58
(-34%)
Severe decline -20.0%, PE contracts to 23.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.4 to 31.7
Stabilization Target:
$100.77
(+25.0%)
PE Expansion Potential:
+25.0%
Share & Embed Analysis
Last updated: September 12, 2026 2:30 AM ET
Data refreshes hourly during market hours. Next update: 3:30 AM
Data refreshes hourly during market hours. Next update: 3:30 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LMAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced LMAT Option Strategies
Professional options setups generated by AI based on today's LMAT price and gamma walls.
